Largest market shown
Germany
$184.3B calculated opportunity across 48 screened products.
Regional export playbook
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Europe regional view
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Largest market shown
$184.3B calculated opportunity across 48 screened products.
Regional footprint
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $184.3B | 48 | Not reported | 16,563 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United KingdomGBR | $146.1B | 30 | Not reported | 17,011 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| NetherlandsNLD | $120.9B | 28 | Not reported | 16,658 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| BelgiumBEL | $76.7B | 13 | Not reported | 16,760 km | 5 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, LiechtensteinCHE | $74.9B | 8 | Not reported | 16,673 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FranceFRA | $64.8B | 20 | Not reported | 16,975 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| ItalyITA | $41.2B | 10 | Not reported | 16,333 km | 11 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts |
| SpainESP | $26.6B | 12 | Not reported | 17,699 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| PolandPOL | $22.9B | 11 | Not reported | 15,608 km | 37 | Telephones for cellular networks or for other wireless networks |
| RussiaRUS | $22.2B | 5 | Not reported | 14,503 km | 10 | Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc |
| CzechiaCZE | $17.5B | 7 | Not reported | 16,098 km | 25 | Telephones for cellular networks or for other wireless networks |
| IrelandIRL | $16.0B | 5 | Not reported | 17,231 km | 11 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| SloveniaSVN | $11.1B | 2 | Not reported | 16,153 km | 8 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| AustriaAUT | $8.5B | 4 | Not reported | 15,989 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| SwedenSWE | $8.0B | 2 | Not reported | 15,609 km | 8 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| DenmarkDNK | $5.2B | 3 | Not reported | 16,054 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| MaltaMLT | $4.1B | 1 | Not reported | 16,101 km | 21 | Vessels: n.e.s. in heading no. 8901, for the transport of goods and other vessels for the transport of both persons and goods |
| HungaryHUN | $3.7B | 2 | Not reported | 15,796 km | 7 | Telephones for cellular networks or for other wireless networks |
| SlovakiaSVK | $3.6B | 2 | Not reported | 15,930 km | 22 | Telephones for cellular networks or for other wireless networks |
| RomaniaROU | $2.4B | 1 | Not reported | 0 km | 0 | Vehicles: parts, gear boxes |
| NorwayNOR | $1.5B | 1 | Not reported | 15,964 km | 4 | Product not reported |
| GreeceGRC | $1.5B | 1 | Not reported | 15,338 km | 4 | Electrical apparatus: photosensitive, including photovoltaic cells, whether or not assembled in modules or made up into panels, light emitting diodes |
| UkraineUKR | $1.4B | 1 | Not reported | 14,957 km | 7 | Product not reported |
Top regional opportunities
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.6B | +12.3% | +0.2% |
| 2 | United KingdomGBR | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $21.6B | +15.3% | +4.1% |
| 3 | BelgiumBEL | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $20.7B | +7.6% | +0.0% |
| 4 | GermanyDEU | HS 850760Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.0% |
| 5 | United KingdomGBR | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $19.3B | +16.1% | +0.0% |
| 6 | NetherlandsNLD | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 7 | Switzerland, LiechtensteinCHE | HS 710813Metals: gold, semi-manufactured | $16.7B | +14.3% | +2.2% |
| 8 | GermanyDEU | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 9 | United KingdomGBR | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.4B | +5.5% | +0.0% |
| 10 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $13.8B | +12.8% | +2.8% |
| 11 | BelgiumBEL | HS 271019Product description unavailable | $12.8B | +9.1% | +0.0% |
| 12 | GermanyDEU | HS 271019Product description unavailable | $12.3B | +5.8% | +0.2% |
| 13 | RussiaRUS | HS 870323Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc | $12.3B | +12.7% | +0.0% |
| 14 | NetherlandsNLD | HS 271019Product description unavailable | $11.9B | +12.2% | +0.0% |
| 15 | ItalyITA | HS 293719Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $11.8B | +29.0% | +0.0% |
| 16 | United KingdomGBR | HS 870380Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 17 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 18 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.0% |
| 19 | GermanyDEU | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.4B | +3.5% | +0.0% |
| 20 | BelgiumBEL | HS 300220Vaccines: for human medicine | $8.0B | +20.4% | +0.0% |
Sector opportunities
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 30
39 screened products with $306.3B of reported buyer imports.
$156.5BCalculated opportunity · +13.1% average growthHS2 85
36 screened products with $198.6B of reported buyer imports.
$127.9BCalculated opportunity · +13.0% average growthHS2 27
13 screened products with $190.0B of reported buyer imports.
$119.1BCalculated opportunity · +11.9% average growthHS2 87
33 screened products with $203.2B of reported buyer imports.
$102.8BCalculated opportunity · +17.0% average growthHS2 00
19 screened products with $194.3B of reported buyer imports.
$84.9BCalculated opportunity · +8.3% average growthHS2 71
12 screened products with $221.9B of reported buyer imports.
$75.2BCalculated opportunity · +10.8% average growthHS2 84
20 screened products with $99.9B of reported buyer imports.
$69.0BCalculated opportunity · +8.6% average growthHS2 29
7 screened products with $32.9B of reported buyer imports.
$33.9BCalculated opportunity · +17.5% average growthFrequently asked questions
Practical guidance for interpreting regional market and product comparisons.
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.